Literature DB >> 2318588

Cefazolin levels after intravitreal injection. Effects of inflammation and surgery.

L Ficker1, T A Meredith, S Gardner, L A Wilson.   

Abstract

Cefazolin (2.25 mg) was injected into the vitreous cavity of phakic, aphakic, and aphakic/vitrectomized rabbits; inflamed eyes were compared to controls. Vitreous levels of cefazolin were determined at selected times from 2 to 48 hr, and the half-life was calculated. The effect of inflammation was to increase the half-life or to reduce the rate of elimination of cefazolin from the vitreous cavity. The drug was cleared substantially faster from aphakic/vitrectomized eyes than from phakic or aphakic eyes. Vitreous levels of cefazolin were above the MIC for most common gram-positive organisms causing endophthalmitis in all study groups at 24 hr, but in only the phakic inflamed eyes and in the aphakic eyes with intact vitreous at 48 hr.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2318588

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  11 in total

1.  Intravitreal clearance of moxifloxacin.

Authors:  Mohan N Iyer; Feng He; Theodore G Wensel; William F Mieler; Matthew S Benz; Eric R Holz
Journal:  Trans Am Ophthalmol Soc       Date:  2005

Review 2.  Factors affecting the efficacy of antibiotics in the treatment of experimental postoperative endophthalmitis.

Authors:  G A Stern
Journal:  Trans Am Ophthalmol Soc       Date:  1993

3.  Endophthalmitis following extracapsular cataract surgery: a review of 32 cases.

Authors:  C J Heaven; P J Mann; D L Boase
Journal:  Br J Ophthalmol       Date:  1992-07       Impact factor: 4.638

4.  Intravenous cefazolin in penetrating eye injuries. I. Effects of trauma and multiple doses on intraocular delivery.

Authors:  D V Alfaro; P E Liggett
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1994-04       Impact factor: 3.117

5.  Pharmacokinetics of sparfloxacin in the serum and vitreous humor of rabbits: physicochemical properties that regulate penetration of quinolone antimicrobials.

Authors:  W Liu; Q F Liu; R Perkins; G Drusano; A Louie; A Madu; U Mian; M Mayers; M H Miller
Journal:  Antimicrob Agents Chemother       Date:  1998-06       Impact factor: 5.191

6.  Pharmacokinetic behavior of intravitreal triamcinolone acetonide prepared by a hospital pharmacy.

Authors:  Masako Oishi; Shinichiro Maeda; Noriyasu Hashida; Nobuyuki Ohguro; Yasuo Tano; Nobuo Kurokawa
Journal:  Jpn J Ophthalmol       Date:  2008-12-17       Impact factor: 2.447

7.  Antimicrobial pharmacokinetics in endophthalmitis treatment: studies of ceftazidime.

Authors:  T A Meredith
Journal:  Trans Am Ophthalmol Soc       Date:  1993

8.  Intravitreal ranibizumab versus vitrectomy for recurrent vitreous haemorrhage after pars plana vitrectomy for proliferative diabetic retinopathy: a prospective study.

Authors:  Irini Chatziralli; Eleni Dimitriou; George Theodossiadis; Evgenia Bourouki; Eleni Bagli; George Kitsos; Panagiotis Theodossiadis
Journal:  Int Ophthalmol       Date:  2019-12-02       Impact factor: 2.031

Review 9.  Pharmacokinetics of intravitreal antibiotics in endophthalmitis.

Authors:  Medikonda Radhika; Kopal Mithal; Abhishek Bawdekar; Vivek Dave; Animesh Jindal; Nidhi Relhan; Thomas Albini; Avinash Pathengay; Harry W Flynn
Journal:  J Ophthalmic Inflamm Infect       Date:  2014-09-10

Review 10.  Review of Intraocular Pharmacokinetics of Anti-Infectives Commonly Used in the Treatment of Infectious Endophthalmitis.

Authors:  Andrea Luaces-Rodríguez; Miguel González-Barcia; María José Blanco-Teijeiro; María Gil-Martínez; Francisco Gonzalez; Francisco Gómez-Ulla; María-Jesús Lamas; Francisco-Javier Otero-Espinar; Anxo Fernández-Ferreiro
Journal:  Pharmaceutics       Date:  2018-05-29       Impact factor: 6.321

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.